# Rhino Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/rhino-health

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.xiranhealth.net/
- Total disclosed funding: $29M
- Latest round: Series B (Mar 27, 2026)
- Investors on record: 6

## About

Established in 2021 and based in Hangzhou, China, Hangzhou Xiran Medical Device Technology Co., Ltd., doing business as Rhino Health, operates as a medical company that engages in the research development and manufacturing of consumables for ophthalmic surgery equipment. The founder is Zhang Chi. The firm currently provides its medical solutions to domestic hospitals and grassroots ophthalmic doctors in China. In March 2026, it raised approximately CNY 100 million in series B funding led by Yuexiu Industrial Investment Funds Management.

Xiran Medical is committed to developing and manufacturing high quality, safe and reliable consumables for ophthalmic surgical equipment. The company also provides one-stop training services for ophthalmic surgeons. The company's main products include cataract phacoemulsification instrument, vitrectomy surgery system, laser vitrectomy system and endoscopic OCT, etc.

The company generates revenue from the direct sale of specialized ophthalmic medical equipment and surgical consumables.

The company plans to use the series B funding to promote its newly approved phacoemulsification and vitrectomy integrated machine in domestic and overseas markets, and to complete the registration, launch, and clinical trials for its next-generation ophthalmic equipment.

## Funding rounds

- Series B, Mar 27, 2026, $14M — Yuexiu Industrial Investment Funds Management, TigerYeah Capital
- Series A, Dec 27, 2023, $14M — Legend Capital, Proxima Ventures, Dalton Venture, Tao Capital, TigerYeah Capital
- Angel, Aug 6, 2021 — TigerYeah Capital

## Investors

- TigerYeah Capital (https://capitalatlas.ai/funds/tigeryeah-capital) — Angel, Series A, Series B
- Legend Capital — Series A
- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series A
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series A
- Tao Capital (https://capitalatlas.ai/funds/tao-capital) — Series A
- Yuexiu Industrial Investment Funds Management (https://capitalatlas.ai/funds/yuexiu-industrial-investment-funds-management) — Series B